Relay Therapeutics Inc (RLAY) Stock Price, Quote & News

Company Profile

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGa...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 370 8837

Website: www.relaytx.com

Address:

399 Binney Street, 2nd Floor, Cambridge, United States

Megaduffman Dec. 3 at 3:40 PM

$RLAY $CAPR

0 · Reply

RandomInvestor777 Nov. 28 at 4:54 PM

$RLAY 2B buyout by JPM?

3 · Reply

Breck100 Nov. 24 at 4:29 PM

$RLAY nice surprise today, wow!

1 · Reply

RonIsWrong Nov. 24 at 4:00 PM

$RLAY 👀 Unusual options activity, along with volume and price jump. 5000 Jan $8 calls at .90 hat tip to @WSRX for catching it

0 · Reply

Winning_calls Nov. 24 at 3:42 PM

$RLAY 😉

0 · Reply

Goldenpoint9 Nov. 24 at 12:58 PM

$RLAY

0 · Reply

mdemattia Nov. 22 at 3:03 AM

$RLAY Relay looks ready to lift off. Too many positives in this stock.

1 · Reply

Winning_calls Nov. 19 at 2:41 PM

$RLAY 😘

0 · Reply

TalkMarkets Nov. 18 at 2:21 PM

Top 3 #Biotech #Stocks Capitalizing On The #AI Revolution $BIOA $NMRA $RLAY https://talkmarkets.com/content/stocks--equities/top-3-biotech-stocks-capitalizing-on-the-ai-revolution?post=538291

0 · Reply

BigDaddyCapital Nov. 17 at 11:00 PM

$RLAY massive buy order after hours 140K shares

0 · Reply

Relay Therapeutics Director Sells $300,000 Worth of Shares. Here's Why Investors Shouldn't Panic.

Dec 3, 2025, 8:47 AM EST - 3 days ago

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares

Nov 22, 2025, 3:23 AM EST - 15 days ago

Relay Therapeutics, Inc. (RLAY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates

Nov 3, 2025, 4:05 PM EST - 4 weeks ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

Oct 30, 2025, 4:05 PM EDT - 5 weeks ago

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

Oct 24, 2025, 1:21 PM EDT - 6 weeks ago

Relay Therapeutics Is A Buy For Its Superb Safety Data

Sep 10, 2025, 2:33 PM EDT - 3 months ago

Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 5, 2025, 6:42 PM EDT - 3 months ago

Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week

Aug 28, 2025, 4:05 PM EDT - 3 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Aug 7, 2025, 5:09 PM EDT - 4 months ago

Relay (RLAY) Q2 Loss Narrows 41%

Aug 7, 2025, 4:05 PM EDT - 4 months ago

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates

Aug 2, 2025, 8:03 AM EDT - 4 months ago

Relay Therapeutics: What's Next For H2 2025?

Jul 31, 2025, 4:05 PM EDT - 4 months ago

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Jun 11, 2025, 4:05 PM EDT - 6 months ago

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Jun 2, 2025, 7:00 AM EDT - 6 months ago

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025

May 29, 2025, 4:05 PM EDT - 6 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

May 8, 2025, 4:05 PM EDT - 7 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

May 5, 2025, 4:05 PM EDT - 7 months ago

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Apr 28, 2025, 4:05 PM EDT - 7 months ago

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Apr 12, 2025, 9:28 AM EDT - 8 months ago

Relay Therapeutics: Trying To Find That Right Price

Feb 26, 2025, 4:05 PM EST - 10 months ago

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Feb 19, 2025, 4:05 PM EST - 10 months ago

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

Feb 14, 2025, 2:17 AM EST - 10 months ago

Relay Therapeutics: A Precision Oncology Play Worth The Risk

Jan 7, 2025, 4:05 PM EST - 11 months ago

Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 6:00 AM EST - 1 year ago

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

Dec 9, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Dec 3, 2024, 8:01 AM EST - 1 year ago

Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Dec 3, 2024, 8:00 AM EST - 1 year ago

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Nov 6, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

Oct 30, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

Sep 16, 2024, 4:57 PM EDT - 1 year ago

Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion

Sep 11, 2024, 6:46 PM EDT - 1 year ago

Why Relay Therapeutics Plummeted by Nearly 14% Today

Sep 11, 2024, 8:15 AM EDT - 1 year ago

Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations

Sep 11, 2024, 8:06 AM EDT - 1 year ago

GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

GME WOOF

Sep 10, 2024, 8:21 PM EDT - 1 year ago

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Sep 10, 2024, 2:50 PM EDT - 1 year ago

Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market

Sep 10, 2024, 10:03 AM EDT - 1 year ago

This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

JCI DK EQR ORCL

Sep 9, 2024, 4:34 PM EDT - 1 year ago

Relay Therapeutics Announces Proposed Public Offering of Common Stock

Sep 9, 2024, 2:16 PM EDT - 1 year ago

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

Sep 9, 2024, 11:30 AM EDT - 1 year ago

Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients

Sep 9, 2024, 7:04 AM EDT - 1 year ago

Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early study

Sep 9, 2024, 6:55 AM EDT - 1 year ago

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Sep 6, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Jun 6, 2024, 7:00 AM EDT - 1 year ago

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

Jun 5, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

May 21, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics to Participate in Upcoming Investor Conferences

May 13, 2024, 8:30 AM EDT - 1 year ago

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

May 2, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

Megaduffman Dec. 3 at 3:40 PM

$RLAY $CAPR

0 · Reply

RandomInvestor777 Nov. 28 at 4:54 PM

$RLAY 2B buyout by JPM?

3 · Reply

Breck100 Nov. 24 at 4:29 PM

$RLAY nice surprise today, wow!

1 · Reply

RonIsWrong Nov. 24 at 4:00 PM

$RLAY 👀 Unusual options activity, along with volume and price jump. 5000 Jan $8 calls at .90 hat tip to @WSRX for catching it

0 · Reply

Winning_calls Nov. 24 at 3:42 PM

$RLAY 😉

0 · Reply

Goldenpoint9 Nov. 24 at 12:58 PM

$RLAY

0 · Reply

mdemattia Nov. 22 at 3:03 AM

$RLAY Relay looks ready to lift off. Too many positives in this stock.

1 · Reply

Winning_calls Nov. 19 at 2:41 PM

$RLAY 😘

0 · Reply

TalkMarkets Nov. 18 at 2:21 PM

Top 3 #Biotech #Stocks Capitalizing On The #AI Revolution $BIOA $NMRA $RLAY https://talkmarkets.com/content/stocks--equities/top-3-biotech-stocks-capitalizing-on-the-ai-revolution?post=538291

0 · Reply

BigDaddyCapital Nov. 17 at 11:00 PM

$RLAY massive buy order after hours 140K shares

0 · Reply

BigDaddyCapital Nov. 17 at 10:27 AM

$RLAY so looks like that SABCS presentation could push this very high

0 · Reply

Winning_calls Nov. 17 at 4:28 AM

$RLAY pick me up $6.35

0 · Reply

Amb8675309 Nov. 13 at 5:15 PM

$RLAY it’s doing well today- wondering reason why

1 · Reply

mdemattia Nov. 10 at 12:52 PM

$RLAY Interested to hear what RLAY has to say today at the Guggenheim Healthcare Conference.

0 · Reply

JarvisFlow Nov. 7 at 6:55 PM

Wells Fargo updates rating for Relay Therapeutics ( $RLAY ) to Equal-Weight, target set at 4 → 6.

1 · Reply

Rstuhlman Nov. 7 at 5:22 PM

$RLAY $7 calls expiring June feels pretty safe 🤷

0 · Reply

Breck100 Nov. 3 at 5:33 PM

$RLAY 10/30/25 Raymond James notes

2 · Reply

Breck100 Nov. 3 at 4:18 PM

$RLAY why the drop today?

0 · Reply

MisterNessuno Oct. 30 at 5:35 PM

$GRRR PS : look at $PACB and $RLAY

0 · Reply

Awiz2 Oct. 28 at 3:01 PM

$RLAY A new high!!! The trend is your friend $20

0 · Reply

Awiz2 Oct. 28 at 2:07 PM

$RLAY Time to run this to $20

0 · Reply

mdemattia Oct. 27 at 11:47 PM

$RLAY volume exploded today.

0 · Reply

Market Cap	1.33B
Revenue (ttm)	10.01M
Net Income (ttm)	-337.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,373.73%
Debt to Equity Ratio	0.00

Volume	898,600
Avg Vol	2,028,928
Day's Range	N/A - N/A
Shares Out	173.32M
Stochastic %K	56%
Beta	1.50
Analysts	Strong Sell
Price Target	$13.90